Cargando…
Impact of Trastuzumab on Ipsilateral Breast Tumor Recurrence for Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer after Breast-Conserving Surgery
PURPOSE: Trastuzumab is effective in early and advanced human epidermal growth factor receptor 2 (HER2)-positive breast cancer. However, few studies have reported the effect of trastuzumab on ipsilateral breast tumor recurrence (IBTR), whose incidence is higher in the HER2-positive subtype than in o...
Autores principales: | Cheun, Jong-Ho, Won, Jiyoung, Jung, Ji Gwang, Kim, Hong-Kyu, Han, Wonshik, Lee, Han-Byoel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Breast Cancer Society
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8250103/ https://www.ncbi.nlm.nih.gov/pubmed/34190441 http://dx.doi.org/10.4048/jbc.2021.24.e33 |
Ejemplares similares
-
Comparison of Long-Term Oncological Outcomes in Oncoplastic Breast Surgery and Conventional Breast-Conserving Surgery for Breast Cancer: A Propensity Score-Matched Analysis
por: Oh, Moon Young, et al.
Publicado: (2021) -
Comparison of Quality of Life and Cosmetic Outcome of Latissimus Dorsi Mini-Flap With Breast Conservation Surgery Without Reconstruction
por: Kim, Jang-il, et al.
Publicado: (2023) -
Retrospective Cohort Study on the Long-term Oncologic Outcomes of Sentinel Lymph Node Mapping Methods (Dye-Only versus Dye and Radioisotope Mapping) in Early Breast Cancer: A Propensity Score-Matched Analysis
por: Lim, Changjin, et al.
Publicado: (2023) -
Prognostic Impact of Time to Ipsilateral Breast Tumor Recurrence after Breast Conserving Surgery
por: Gosset, Marie, et al.
Publicado: (2016) -
Unique Features of Young Age Breast Cancer and Its Management
por: Lee, Han-Byoel, et al.
Publicado: (2014)